StockData
Personalis, Inc. logo

Personalis, Inc. (PSNL) stock

PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30344% above fair value
$14.80+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.58BP/E –Yield –

Personalis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Personalis's price to sales ratio was 24.4× on Nov 11, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 0.7× to 25.6×, with a median of 3.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202624.4×+14.1
2025Dec 31, 202510.2×+5.6
2024Dec 31, 20244.7×+3.2
2023Dec 29, 20231.5×+0.1
2022Dec 30, 20221.3×−6.2
2021Dec 31, 20217.5×−11.0
2020Dec 31, 202018.5×+12.9
2019Dec 31, 20195.6×–

More Personalis figures

See a number that looks wrong?